Anglo American lowered its 2027 copper guidance as production fell in the fourth quarter. Diamond output fell 35% on year to 3.8 million carats, a decrease mainly driven by maintenance closures at its ...

Bristol-Myers Squibb Company BMY reported fourth-quarter 2025 adjusted earnings per share (EPS) of $1.26, which beat the Zacks Consensus Estimate of $1.15. In the year-ago quarter, BMY posted adjusted ...

Bristol-Myers Squibb Co (BMY) reports robust growth in its new product portfolio while navigating revenue declines in its legacy offerings.

Eli Lilly and Company (NYSE:LLY) Q4 2025 Earnings Call Transcript February 4, 2026 Eli Lilly and Company beats earnings ...

Balochistan, Pakistan's largest and least developed province, is rich in untapped minerals valued at up to $6 trillion, including significant reserves of copper, gold, and coal.

Pfizer Inc. (NYSE:PFE) Q4 2025 Earnings Call Transcript February 3, 2026 Pfizer Inc. beats earnings expectations. Reported ...

Discover J&J’s pipeline strategy for 2026 as it it projects that its sales for the year will be between $100 billion and $101 ...

Good afternoon, everyone, and welcome to our fourth quarter 2025 earnings call. Bob Bradway will lead the call today and be ...

Production Report for the fourth quarter ended 31 December 2025 Duncan Wanblad, CEO of Anglo American, said: ‘We delivered another strong production quarter in our Copper and Premium Iron Ore ...

Thank you, and welcome to everybody joining us today. Alongside this, we're continuing to make excellent progress in R&D, strengthening our late-stage portfolio and already securing four FDA approvals ...

Eli Lilly and Company (NYSE: LLY) today announced its financial results for the fourth-quarter of 2025 and provided 2026 financial guidance.

Pharming Group has transitioned from a speculative play to a fundamentally attractive, cash-generating rare disease company.